Figure 2.

Non-fasting blood glucose and hemodynamic parameters. Columns indicate values of Ctrl, Mat, DCM, and DCM+Mat in a (mean±SD) manner respectively. (A) Non-fasting blood glucose concentration was examined after matrine pretreatment and before STZ injection. (B) Non-fasting blood glucose concentration was examined 4 weeks after the second STZ injection. (C) and (D) LVEDP, LVSP, +LVdP/dt_max, and –LVdP/dt_max in different groups were detected by invasive hemodynamic determination 12 weeks after non-fasting blood glucose tests. ^bP<0.05, ^cP<0.01 vs Ctrl. ^eP<0.05, ^fP<0.01 vs Mat. ^hP<0.05 vs DCM.